RankingsPricing
  1. JP-listed companies
  2. SymBio Pharmaceuticals Limited

SymBio Pharmaceuticals LimitedJP:4582

Market cap
¥11.4B
P/E ratio
Back to summarized table
Income statementBalance sheetCash flow
Dec 31,
2015		Dec 31,
2016		Dec 31,
2017		Dec 31,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2021		Dec 31,
2022		Dec 31,
2023
Net sales-------10,0085,590
Cost of sales-------2,4081,179
Cost of sales-------2,4081,179
Gross profit (loss)-------7,6004,411
Selling, general and administrative expenses-------5,6365,223
Operating profit (loss)-------1,964-812
Interest income-------012
Foreign exchange gains-------136117
Other-------34
Non-operating income-------139133
Commission expenses-------5713
Share issuance costs-------4611
Provision for office transfer expenses--------25
Loss on retirement of non-current assets-------18
Non-operating expenses-------10357
Ordinary profit (loss)-------2,000-736
Gain on reversal of share acquisition rights-------106101
Extraordinary income-------106101
Impairment losses--------561
Extraordinary losses--------561
Profit (loss) before income taxes-------2,106-1,195
Income taxes - current-------39623
Income taxes - deferred-------531745
Income taxes-------927767
Profit (loss)-------1,179-1,963
Profit (loss) attributable to owners of parent-------1,179-1,963